Opinion|Videos|January 6, 2025
The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care
A panelist discusses how digital patient engagement tools and collaboration with advocacy groups can enhance treatment adherence and care coordination while providing vital support and resources for individuals managing Lambert-Eaton myasthenic syndrome (LEMS).
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How can patient engagement tools and technology improve adherence and patient satisfaction in LEMS treatment?
- What role do patient advocacy groups play in supporting care coordination and resource allocation for LEMS patients?
Advertisement
Related to this article
Adults with moderately to severely active Crohn disease can now start risankizumab with an on-body injector at home.
For all the advances in breast cancer, there remains unmet need for patients whose cancer progresses after treatment with antibody-drug conjugates (ADCs). In the final week of Breast Cancer Awareness Month, AJMC® looks at an investigational vaccine approach that could come after ADCs, offering patients a low-toxicity regimen.
Hiddo Heerspink, PhD, discusses finerenone data in type 1 diabetes, FSGS and IgA nephropathy, and open questions on sequencing CKD therapies.
Advertisement
Advertisement
Trending on AJMC
1
Preparing for Hepatitis B Functional Cure: Jordan Feld, MD, MPH
2
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
3
FDA Approves Talazoparib Plus Enzalutamide for HRR-Mutated mHSPC
4
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
5